Poliovirus shedding after the first and second doses of trivalent polio vaccines in newborns
Background The trivalent oral polio vaccine (tOPV) produced by Bio Farma consists of three live, attenuated poliovirus serotypes (1, 2, and 3). The tOPV stimulates the formation of secretory IgA (sIgA) on the intestinal wall and lumen. The existence of sIgA is considered giving immunity in the intes...
Main Authors: | Viramitha K. Rusmil, Meita Dhamayanti, Sunarjati Soedigdo Adi, Imam Megantara |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesian Pediatric Society Publishing House
2015-07-01
|
Series: | Paediatrica Indonesiana |
Subjects: | |
Online Access: | https://paediatricaindonesiana.org/index.php/paediatrica-indonesiana/article/view/31 |
Similar Items
-
The global switch from trivalent oral polio vaccine (tOPV) to bivalent oral polio vaccine (bOPV): facts, experiences and lessons learned from the south-south zone; Nigeria, April 2016
by: Bassey Enya Bassey, et al.
Published: (2018-01-01) -
Poliomyelitis seroprevalence in high risk populations of India before the trivalent-bivalent oral poliovirus vaccine switch in 2016
by: Mohammad Ahmad, et al.
Published: (2021-01-01) -
Vaccine-related poliovirus shedding in trivalent polio vaccine and human immunodeficiency virus status: analysis from under five children
by: Joanne Hassan, et al.
Published: (2017-11-01) -
Perbandingan Manfaat Vaksin Oral Polio 1 (Monovalen) dengan Vaksin Oral Polio Trivalen Terhadap Transmisi Virus Polio 1 dalam Upaya Mengatasi Kejadian Luar Biasa Polio 1 di Indonesia Tahun 2005: ditinjau melalui respons imun dan keamanannya
by: Kusnandi Rusmil
Published: (2016-11-01) -
Immunogenicity of a combined schedule of trivalent oral and inactivated polio vaccines in South African infants
by: Shelina Moonsamy, et al.
Published: (2019-07-01)